Sycomore Asset Management Pfizer Inc Transaction History

Sycomore Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 05, 2023	BUY	$41.75 - $54.5 $1.87 Million - $2.44 Million	44,765 Added 184.22%	69,065 $3.58 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $1.23 Million - $1.46 Million	-26,525 Reduced 52.19%	24,300 $1.23 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $2.02 Million - $2.5 Million	-44,052 Reduced 46.43%	50,825 $2.68 Million
Q4 2021 Jan 14, 2022	BUY	$41.32 - $61.25 $3.92 Million - $5.81 Million	94,877 New	94,877 $5.46 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $117,750 - $151,260	-3,000 Closed	0 $0
Q2 2021 Nov 04, 2021	BUY	$35.91 - $40.68 $107,729 - $122,040	3,000 New	3,000 $117,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sycomore Asset Management, based on Form 13F filings with the SEC.

Stay updated on Sycomore Asset Management with notifications on news.